We are live on
!
Find out more
Travere Therapeutics
TVTX
TVTX
130 hedge funds and large institutions have $934M invested in Travere Therapeutics in 2018 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
5% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 44
2.72% less ownership
Funds ownership: 105.56% → 102.83% (-2.7%)
23% less capital invested
Capital invested by funds: $1.21B → $934M (-$273M)
Holders
130
Holding in Top 10
4
Calls
$9.46M
Puts
$5.17M
Top Buyers
| 1 | +$16.2M | |
| 2 | +$8.45M | |
| 3 | +$5.33M | |
| 4 |
D.E. Shaw & Co
New York
|
+$4.54M |
| 5 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$4.4M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$15.1M | |
| 3 | -$12.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.17M |
| 5 |
Millennium Management
New York
|
-$5.68M |